Progressive supranuclear palsy: diagnosis and management.
Rowe JB, Holland N, Rittman T.
Pract Neurol. 2021 Oct;21(5):376-383. doi: 10.1136/practneurol-2020-002794. Epub 2021 Jul 2.
Progressive supranuclear palsy.
Giagkou N, Höglinger GU, Stamelou M.
Int Rev Neurobiol. 2019;149:49-86. doi: 10.1016/bs.irn.2019.10.013. Epub 2019 Nov 21.
[Progressive supranuclear palsy].
Fedorova NV, Bril EV, Kulua TK, Mikhaylova AD.
Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(5):111-119. doi: 10.17116/jnevro2021121051111.
Progressive supranuclear palsy: Advances in diagnosis and management.
Coughlin DG, Litvan I.
Parkinsonism Relat Disord. 2020 Apr;73:105-116. doi: 10.1016/j.parkreldis.2020.04.014. Epub 2020 May 25.
Progressive supranuclear palsy.
Golbe LI.
Semin Neurol. 2014 Apr;34(2):151-9. doi: 10.1055/s-0034-1381736. Epub 2014 Jun 25.
Progressive Supranuclear Palsy: Challenges and Considerations for Care Transitions.
Wodwaski N.
Crit Care Nurs Clin North Am. 2023 Dec;35(4):393-401. doi: 10.1016/j.cnc.2023.05.008. Epub 2023 Jun 17.
Progressive supranuclear palsy.
Duvoisin RC, Golbe LI, Lepore FE.
Can J Neurol Sci. 1987 Aug;14(3 Suppl):547-54.
Progressive supranuclear palsy.
Boeve BF.
Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S192-4. doi: 10.1016/S1353-8020(11)70060-8.
Progressive Supranuclear Palsy: an Update.
Armstrong MJ.
Curr Neurol Neurosci Rep. 2018 Feb 17;18(3):12. doi: 10.1007/s11910-018-0819-5.
Progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration.
Fabbrini G, Fabbrini A, Suppa A.
Handb Clin Neurol. 2019;165:155-177. doi: 10.1016/B978-0-444-64012-3.00009-5.
